Showing results (51-60 of 88) with videos related to
Sort By:
Pageof 9
Neurologia Medico-Chirurgica|October 22, 2013
New treatment strategies to eradicate cancer stem cells and niches in glioblastomaTakuichiro Hide, Keishi Makino, Hideo Nakamura, et al.Cancer Research|November 19, 2009
Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomasRaymund L Yong, Naoki Shinojima, Juan Fueyo, et al.Cancer Research|September 3, 2010
The RB-E2F1 pathway regulates autophagyHong Jiang, Vanesa Martin, Candelaria Gomez-Manzano, et al.Journal of Neurosurgery|August 18, 2004
The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiformeNaoki Shinojima, Masato Kochi, Jun-ichiro Hamada, et al.Neuro-Oncology Advances|May 1, 2024
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphomaHajime Yonezawa, Yoshitaka Narita, Motoo Nagane, et al.Human Cell|September 30, 2021
Macrophage/microglia-derived IL-1β induces glioblastoma growth via the STAT3/NF-κB pathwayKeitaro Kai, Yoshihiro Komohara, Shigeyuki Esumi, et al.Cancer Research|February 1, 2013
TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cellsNaoki Shinojima, Anwar Hossain, Tatsuya Takezaki, et al.Endocrine Journal|June 14, 2019
Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomasYoshihiro Takesue, Fan-Yan Wei, Hiroyuki Fukuda, et al.World Neurosurgery|August 11, 2018
A Rare Case of Thyrotropin-Secreting Pituitary Adenoma Coexisting with Papillary Thyroid Carcinoma Presenting with Visual Disturbance without HyperthyroidismHirotaka Inoue, Naoki Shinojima, Ryuta Ueda, et al.Neuro-Oncology Advances|September 25, 2023
Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinibYoshiki Arakawa, Yoshitaka Narita, Motoo Nagane, et al.Pageof 9